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Food-Derived Opioids: Production 
and the Effects of Opioids on 
Human Health
Sevda Arısoy, Işık Çoban and Özlem Üstün-Aytekin
Abstract
Traditional opioids have been used for the people who suffer from cancer, burns, 
surgery, HIV/AIDS, and other serious illness pains for years. However, numerous 
side effects like dizziness, apnea, physical dependence, tolerance, addiction, nau-
sea, and vomiting push the researchers to look forward to the new opioid options. 
The opioid peptides which derived from foods provide significant advantages as the 
safe and natural alternative. The researchers reported that it is also promising a new 
functional food and nutraceutical. In this chapter, the type of food-derived opioids, 
their origins, possible receptors, their amino acid sequences, opioid effects, produc-
tion techniques, and health benefits are reviewed.
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1. Introduction
Opioids have been acting on endogenous and exogenous opioidergic systems 
of the human. Endogenous opioids are generated in the human body. The system 
consists of mu (μ), delta (δ), kappa (κ), and nociception receptors (Figure 1) and 
their ligands (β-endorphins, enkephalins, dynorphins, and nociceptin/orphanin 
FQ ) [1, 2]. The amino acid sequence of these opioids is almost the same as YGGF, 
except nociception/orphanin FQ [3].
Exogenous opioid peptides can bind act like endogenous. The most popular 
sample of exogenous opioids is morphine. It is a strong opioid isolated from plants 
and produced synthetically [3]. The chemical structure of morphine consists of a 
benzylisoquinoline alkaloid with two additional ring closures (Figure 1). Morphine, 
in both injectable and oral fast-acting formulations, can be used for acute and 
chronic pain and acts directly on the central nervous system (CNS). The most com-
mon application area is pain due to cancer, burns, surgery, HIV/AIDS, and other 
serious illnesses [4].
During the past two decades, morphine consumption reached almost record 
level 523 tons in 2013 followed by codeine and thebaine as 361 tons and 246 tons, 
respectively. The United States was the leader with 57.3% of global morphine 
consumption and followed by European countries (22.5%) and Canada (7.7%) [5].
Increasing of morphine and/or other opioid consumption has parallel 
increases in opioid overdoses. Because of the adverse effects of the exogenous 
opioids on human health such as dizziness, apnea, physical dependence, toler-
ance, nausea, vomiting, and addiction, interest in morphine-like food-derived 
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Opioid peptide Source Amino acid 
sequence
Opioid 
receptor
Opioid effect Reference
β-casomorphine-4 β-Casein/milk YPFP μ Opioid agonist [6, 7]
β-casomorphine-5 β-Casein/milk YPFPG μ Opioid agonist [6, 7]
β-casomorphine-6 β-Casein/milk YPFPGP μ Opioid agonist [6, 7]
β-casomorphine-7 β-Casein/milk YPFPGPI μ Opioid agonist [6, 7]
Lactoferroxin A Lactoferrin/milk YLGSGY μ Opioid antagonist [8, 9–11]
Lactoferroxin B Lactoferrin/milk RYYGY κ Opioid antagonist [8, 9–11]
Lactoferroxin C Lactoferrin/milk KYLGPGY κ Opioid antagonist [8, 9–11]
α-Lactorphin α-Lactalbumin/milk YGLF μ Opioid agonist [12, 13]
β-Lactorphin β-Lactoglobulin/milk YLLF μ Opioid agonist [12, 13]
Casoxin A κ-Casein/milk YPSYGLN μ Opioid antagonist [6, 14, 15]
Casoxin B κ-Casein/milk YPYY μ Opioid antagonist [6, 14, 15]
Casoxin C κ-Casein/milk YIPIQYVLSR μ Opioid antagonist [6, 14, 15]
Casoxin D α-Casein/milk YVPFPPF μ Opioid antagonist [6, 14, 15]
Serorphin Bovine serum protein YGFQNA δ Opioid agonist [16, 17]
Hermorphin Hemoglobin YPWT μ Opioid agonist [16, 17]
Gluteomorphine 
A4
Wheat protein GYYP δ Opioid agonist [6, 18]
Gluteomorphine 
A5
Wheat protein GYYPT δ Opioid agonist [6, 18]
Gluteomorphine 
B4
Wheat protein YGGW δ Opioid agonist [6, 18]
Gluteomorphine 
B5
Wheat protein YGGWL δ Opioid agonist [6, 18]
Gluteomorphine 
C5
Wheat protein YPISL δ Opioid agonist [6, 18]
Gluteomorphine 7 Wheat protein YPQPQPF δ Opioid agonist [6, 18]
Soymorphine-5 Soy protein YPFVV μ Opioid agonist [19–21]
Figure 1. 
(a) Chemical structure of morphine, (b) The opioid receptors in human body.
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opioid peptides, exorphins, has been increased by researchers. Exorphins are 
generated from exogenous proteins, such as milk, meat, cereal, plant, or egg by 
enzymatic digestion [3, 8]. They across the blood-brain barrier, interact with opi-
oid receptors, and stimulate analgesic activity and sedative effect on the nervous 
system. Most of the food-derived exorphins were tested for the opioid activity, 
and amino acid sequences were identified. The results showed that the exorphins 
generally have a tyrosine (Tyr; Y) residue at the amino terminal end (except 
α-casein opioids) (Table 1).
On the other hand, due to the lack of digestive enzymes in some people and 
their sensitivities on opioids, food-derived opioid peptide consumption might be 
involved in some important diseases. For example, the increase in β-casomorphin 
formation from β-caseins of either human or cow milk has a correlation with 
the sudden infant death (SID) syndrome [27, 28]. After the penetration of 
β-casomorphins into the infants’ immature central nervous system, the respira-
tory center in the brain stem may be inhibited, resulting in breathing abnormality, 
hypercapnia, apnea, and mortality [29]. Moreover, in atopic eczema (a relapsing 
skin disease prevalent on infants’ face, knees, and elbows), induced immune cells 
form β-casomorphin from breast milk β-caseins, resulting in histamine secre-
tion that causes allergic skin reactions. The reason for this is the lack of DPPIV 
enzyme which is negatively correlated with the amount of β-casomorphin [30]. 
The DPPIV enzyme is also effective on autistic children on the treatment of some 
symptoms (e.g., insensitivity to pain, digestion problems, attention problems) 
which are caused by the effects of β-casomorphins and gluteomorphins [31]. 
β-casomorphins may also cause depression which is a significant risk factor for 
cardiac patient men [32].
2. Bioactive peptides and generation of the opioid peptides
Food proteins provide numerous important biologically active peptides. These 
peptides can be released by gastrointestinal digestive enzymes during digestion, 
ripening processes or fermentation with proteolytic starter culture and hydrolyz-
ing with commercial protease derived from microorganisms or plants [6, 33]. 
Many recent articles have been focused on the effect of bioactive peptides on 
human health. Generally, these peptides are known as specific peptide fragments 
that have a positive effect on human body systems, functions, and conditions 
depending on their amino acid composition and sequence [7, 34]. Oral adminis-
tration of the bioactive peptides may affect the nervous, cardiovascular, immune, 
and digestive system. Opioid peptides are one of the most studied bioactive 
peptides (Figure 2).
Opioid peptide Source Amino acid 
sequence
Opioid 
receptor
Opioid effect Reference
Soymorphine-6 Soy protein YPFVVN μ Opioid agonist [19–21]
Soymorphine-7 Soy protein YPFVVNA μ Opioid agonist [19–21]
Rubiscolin-5 Spinach protein YPLDL δ Opioid agonist [22–24]
Rubiscolin-6 Spinach protein YPLDLF δ — [22–24]
Oryzatensin Rice protein GYPMYPLPR μ Opioid antagonist [8, 25, 26]
Ovalulin Ovalbumin/egg YPLDLF δ — [8, 9–11]
Table 1. 
Food-derived opioid peptides, amino acid sequences, opioid receptors, opioid effects, and production method.
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3. Opioid peptides derived from animal protein
Because of the protein structures, milk proteins (80% casein; αS1-casein, 
αS2-casein, β-casein, and κ-casein and 20% whey protein; α-lactalbumin, 
β-lactoglobulin, serum albumin, immunoglobulins, and lactoferrins) have a 
great potential to occurrence of opioid peptides by fermentation, heat treat-
ment, or enzymatic hydrolysis [35, 36]. Hydrolysis of these milk proteins lead 
to generate peptides that may have opioid activity. The milk-derived opioids 
have been named as β-casomorphins (β-casein), lactoferroxins (lactoferrin), 
casoxin (κ-casein, α -casein), α-lactorphin (α-lactalbumin), and β-lactophin 
(β-lactoglobulin) [9, 37]. β-casomorphins, the milk origin opioid peptides, were 
firstly detected in the infant’s gastrointestinal system and blood plasma [10]. 
Then, the same structure was found in raw, processed sheep, buffalo, and human 
milk and fermented dairy products. The β-casomorphin group derived from 
β-casein consists of short-chain peptides such as β-casomorphin-4,-5,-6, and-7, 
and they act as opioid agonists on μ-type opioid receptors [9–11]. Researchers 
indicated that β-casomorphin is responsible for the calming effect of milk and 
stimulation of insulin and somatostatin release [12].
Lactoferrin is an iron-binding glycoprotein and known as a whey protein. It 
can be found not only in milk but also in secretion fluids such as tears, saliva, and 
synovial fluids. Lactoferrin is involved in many biological activities in human-like 
antimicrobial and anti-inflammatory effects and stimulating iron absorption [13]. 
After digestion, lactoferroxin A, B, and D forms are produced (Table 1). While 
lactoferroxins B and C act as an opioid antagonist to the κ-type receptor, lactofer-
roxin A acts opioid antagonists on μ-type opioid receptors. All lactoferroxin forms 
have weak opioid activities [8, 14–16].
α-lactorphin and β-lactorphin are derived from α-lactalbumin (bovine and 
human) and β-lactoglobulin (bovine), respectively. These two lactorphins are 
Figure 2. 
Generation of bioactive peptides from foods and opioids.
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opioid agonist to the μ-type receptor; they inhibit the angiotensin-converting 
enzyme activity (ACE) and have been shown to have a smooth muscle contracting 
effect [17, 38].
All κ-casein fragments are known as casoxins that are produced by digestion of 
bovine casein with pepsin and trypsin. Casoxins A, B, and C were obtained from 
κ- casein by the enzymatic digestion, and casoxin D was produced from α-casein in 
bovine milk. Casoxins are the opioid antagonist to μ-type receptor-like lactoferrins, 
and casoxin C have the highest biological potency, and researchers reported that it 
can inhibit the ACE activity [9, 39, 40].
Other opioid peptides from animal sources are serorphin, historphin, valentor-
phin, kapporphin, hemorphin, and ovalulin. Serorphin has a δ-type opioid receptor 
ligand with agonist activity and generated from bovine serum proteins by digestion 
with pepsin. Historphin (YGFGG) and valentorphin (YGFIL) are structurally 
similar to the serorphin which are derived from histone H4 and carboxypeptidases 
A and B, respectively. An effective opioid on peristaltic movement, bladder spasm, 
and pain management, hemorphin is derived from digested hemoglobin, passes 
the blood-brain barrier, and acts as an opioid agonist to μ-type receptors [41, 42]. 
Researchers have reported that there is very limited knowledge about the last two 
opioid peptides: ovalulin and kapporphin. The origin of ovalulin is ovalbumin that 
is an egg protein and synthesized as a homolog of rubiscolin (spinach opioid) [43]. 
Kapporphin (YSFGG) is derived from immunoglobulin κ-chain [18].
4. Opioid peptides derived from plant/cereal protein
Among the possible opioids in plants, the major opioids are gluten exorphins 
(gluteomorphins, gliadorphins) that consist of a combination of gliadin and glutenin 
proteins and are found in some grains such as wheat, rye, barley, and oats. Studies 
have shown that gluteomorphins act as opioid agonists on δ-type opioid receptors and 
consist of gluteomorphin A4, A5, B4, B5, C, and 7. These are resistant to the intestinal 
and enterobacterial proteinases, cross the human intestinal epithelium, enter the 
bloodstream, and interfere with the central nervous system [9, 43–47]. Gluteomorphin 
A5 has been associated with antinociceptive effect and modulation of memory 
process and affects peripheral nervous system and central nervous system. Takahashi 
et al. [19] and Fanciulli et al. [44] revealed that gluteomorphin B5 induced prolactin 
secretion after peripheral injection in rats. Gluteomorphin C reduced anxiety and 
developed learning ability after consumption [9]. Casomorphins and gluteomorphins 
are associated with autism spectrum disorder because these opioid peptides found in 
the urine samples of autistic patients and removing casein and gluten proteins from 
autistic children’s diet may improve learning abilities, concentration, attention and 
language problems, eye contact, and digestion problems [21, 31].
Soy protein is one of the widely used cereals in foods for gelation, emulsifica-
tion, and viscosity [3]. Soymorphins are derived from the soybean β-conglycinin 
β-subunit by digestion with pancreatic elastase and leucine aminopeptidase and act 
as opioid agonists’ anxiolytic-like activity on μ-type opioid receptors. The opioid 
activity of the soymorphin is twice than β-casomorphin. Soymorphin fractions 
consist of soymorphin-5, soymorphin-6, and soymorphin-7 had anxiolytic effects 
with oral administration at doses of 10–30 mg/kg in mice [23]. Oral administration 
of soymorphin suppresses food intake, especially soymorphin-7 which is more 
effective in suppressing food intake than soymorphin-5 and soymorphin-6 [24]. 
Soymorphins inhibit anxiety and overeating and are also effective on glucose and 
lipid metabolism. Soymorphin-5 associated with decreasing triglycerides both the 
plasma and liver in diabetic mice [25].
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Rubiscolins are derived from spinach protein by digestion with pepsin. 
Rubiscolin-5 and rubiscolin-6 are opioid agonist to δ-type receptor. Oral adminis-
tration at different doses of rubiscolin-6 may have an analgesic effect and anxiolytic 
effect and stimulate food intake and memory consolidation in mice [26, 48, 49].
Oryzatensin is derived from digestion of rice albumin with trypsin and acts as 
opioid antagonists on μ-type opioid receptors, and also oryzatensin has an affinity 
to C3a receptors and immunomodulating activities [8, 50, 51].
5. Production of food-derived exogenous opioid peptides
Although food sources do not exhibit opioid activity in their own right, the 
peptide products of the proteins of these foods can exhibit opioid activity. For the 
efficient production of opioids by using food proteins as substrate, three different 
production methods were mentioned: chemical digestion, enzymatic gastrointesti-
nal or commercial hydrolysis, and microbial production.
5.1 Chemical digestion
On the purpose of improving protein digestion and peptide formation, acid 
hydrolysis is applied to food protein-rich substrate. For cheeses (e.g., Mozzarella), 
the profile of produced bioactive peptide might be affected from the type of acid 
used for hydrolysis [52]. Conventional conditions for acid hydrolysis (6 M HCl 
treatment at 110° C for more than 24 h) can cause the destruction of amino acids 
(e.g., tryptophan) [53]. On the other hand, in the food industry, alkali treatment is 
quite rarely applied for protein hydrolysis because of the loss of protein digestibility 
[52] and it can reduce arginine, cystine, serine, threonine, lysine, and/or isoleucine 
content and form unexpected amino acid residual forms such as lanthionine or 
lysinoalanine. Because of the difficulty of controlling chemical processes and yield-
ing products with modified amino acids, the other treatment methods (enzymatic, 
fermentation) are preferred in bioactive peptide productions [53].
5.2 Enzymatic hydrolysis
A common way to produce opioid bioactive peptides is enzymatic hydrolysis, 
and the production of opioid peptides via enzymatic hydrolysis is mostly carried 
out by using microbial enzymes (e.g., thermolysin, alcalase) and gastrointestinal 
enzymes (e.g., trypsin, chymotrypsin, pepsin, and pancreatin) [54–56]. In some 
studies, an increase in opioid activity was reported by using a combination of 
gastrointestinal enzymes and microbial enzymes [54, 55]. Moreover, the compo-
nents of these combinations are also significant in opioid types and concentrations. 
For example, food proteins are hydrolyzed by pepsin to produce opioids. Besides, 
pepsin-thermolysin combination produces gluten exorphins A5, B5, A4, and B4, 
while trypsin-chymotrypsin-pepsin hydrolysate forms gluten exorphin C [54, 55]. 
The pepsin-elastase hydrolysate, with its 250 μg/g concentration, has almost 5 times 
higher gluten exorphin A5 concentration than pepsin-thermolysin hydrolysate 
(40 μg/g) [57]. Soymorphin-4 and soymorphin-5 are released from soy protein 
by the activity of elastase and leucine aminopeptidase; however, soymorphin-6 is 
released by pepsin and pancreatic elastase activity [43]. Enzymatic hydrolysis is 
carried out by the following method regardless of the food protein used (Figure 3): 
preparation of raw material for enzymatic hydrolysis (size reduction, etc.), homog-
enization in buffer, temperature, and pH adjustment to the optimum values of the 
enzyme, and hydrolysis of food product by enzyme (ultrasonic-assisted hydrolysis 
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for low molecular weight peptide production) [58, 59]. After inactivating or sepa-
rating enzymes from hydrolysate, bioactive peptides are separated from the non-
product residuals (e.g., lipids and precipitate) by centrifugation and decantation, 
subsequently fractionated (e.g., ultrafiltration, nanofiltration, electrodialysis), and 
then stabilized (e.g., spray drying) [60–62].
For producing desired peptides, using a proper enzyme and optimizing reaction 
conditions (e.g., time, pH, amount of the enzyme, temperature) are highly important 
[62]. For example, thermolysin enzyme obtained from Bacillus thermoproteolyticus 
has an optimum activation temperature range between 65 and 85°C and optimum pH 
between 5 and 8.5, while Bacillus licheniformis alcalase is active around 50°C and pH 8.
5.3 Microbial production
The use of protease-secreting microbial strains is an alternative method for 
chemical proteolysis and enzymatic hydrolysis for hydrolysis of food protein-rich 
substrates [63]. Enzymes secreted from microorganisms depending on the type of 
microbial production provide the secretion of opioids by hydrolyzing a protein-rich 
substrate [9]. The peptides produced during fermentation exhibit a high bioactivity 
Figure 3. 
Flow diagram to produce bioactive opioids.
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and better opioid functions. For the fermentation of protein-rich sources to pro-
duce bioactive peptides, Lactobacillus is one of the most widely employed genera 
[9–26, 38–63]. Due to the use of lactic acid bacteria, protein-rich substrates become 
acidified because of lactic acid production. Lactic acid existence in the production 
media provides a microbiologically safe environment for production and extent 
shelf life of the opioid product because of the organic acid feature of lactic acid [63]. 
Lactobacillus helveticus L89 X-prolyl dipeptidyl aminopeptidase (Pep X)-deficient 
mutant strain was used for milk fermentation to produce β-casomorphin-4 [64].
Enzymatic proteolysis of Lactobacillus GG-fermented ultra-high temperature 
milk substrate by pepsin and trypsin resulted in the release of some opioid sequences 
(RYLGYLE, YPFP, YPFPGPIPNSL, YGLF) [65]. L. delbrueckii ssp. bulgaricus and 
S. salivarius ssp. thermophilus produce β-casomorphin precursors from fermented 
yogurt. But they cannot produce β-casomorphin because of an inability of these 
bacteria to hydrolyze β-casein to β-casomorphin. Bacillus cereus and Pseudomonas 
aeruginosa are also able to produce β-casomorphin from the fermentation of milk. 
Kluyveromyces marxianus var. marxianus can produce β-lactorphin from whey [9].
In addition, it is possible to produce opioid peptides from fungi fermentation. In 
Brie, Gouda, Gorgonzola, Cheddar, and Fontina cheeses, β-casomorphin was also 
detected in different concentrations.
To sum up, opioid peptides are promising new exogenous opioids because 
they are free from adverse effects on human health. Due to this feature, there is a 
growing interest to elucidate the function of food-derived opioid peptides in the 
human body. The production techniques of food-derived opioid peptides are mostly 
based on hydrolysis of food proteins by using commercial or/and gastrointestinal 
enzymes. Also, some of the researchers conclude that food-derived opioid peptides 
may be carefully considered as new nutraceutical candidates.
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